Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Despite promising results in using deep learning to infer genetic features from histological whole-slide images (WSIs), no prior studies have specifically applied these methods to lung adenocarcinomas from subjects who have never smoked tobacco (NS-LUAD) – a molecularly and histologically distinct subset of lung cancer. Existing models have focused on LUAD from predominantly smoker populations, wi...
A minority of driver mutations in cancer significantly alter protein structure and key functionalities, thereby driving cancer progression. Consequently, the prediction and identification of driver mutations hold critical implications for targeted cancer therapy. This study introduces MultiAlloDriver, a novel multi-modal machine learning model based on an attention mechanism, which for the first t...
The high rate of local recurrence in gastric adenocarcinoma (GA) suggests that carcinogenesis is not a focal event but a field-wide process. This phen...
Deep learning shows promise in structure-based drug discovery, yet challenges persist in generating pharmacologically plausible molecules with valid 3...
While gene sequencing is routine in cancer care, translating sequences into treatment decisions remains a challenge. Here we introduce MutationProject...
Lung adenocarcinoma (LUAD), the most common subtype of non–small cell lung cancer (NSCLC) exhibits profound histological and molecular heterogeneity, ...
Linking spatial transcriptomic data to clinically relevant phenotypes is essential for advancing spatially informed precision oncology. Here, we prese...
B-cells get activated through interaction with B-cell epitopes, a specific portion of the antigen. Identification of B-cell epitopes is crucial for a ...
Advances in single-cell sequencing have enabled detailed characterization of T-cell clonal dynamics in cancer. However, analyses aiming to link transc...
Breast cancer (BRCA) is a leading cause of cancer-related mortality in women, characterized by marked heterogeneity in molecular subtypes, immune micr...
The molecular landscape of lung adenocarcinoma (LUAD) is often summarized as a “pie chart” of driver oncogenes, suggesting identification and targetin...
T-cells play a key role in adaptive immunity by mounting specific responses against diverse pathogens. An effective binding between T-cell receptors (...
Precision medicine aims to identify significant biomarkers and effective drugs tailored to individual genomic profiles, thereby enabling personalized ...
Deciphering cell type-specific perturbation effects on genes and cellular states demands considerable experimental resources. To overcome this challen...
While a differentiation hierarchy with leukemia-initiating stem cells (LICs) at the apex is well documented for acute myeloid leukemia, the existence ...
Homologous recombination deficiency (HRD) is a critical biomarker for guiding treatment decisions in high-grade serous tubo-ovarian carcinoma (HGSOC),...
Reconstructing individual patient data (IPD) from Kaplan–Meier (KM) plots provides valuable insights for evidence synthesis in clinical research. Howe...
Identification of mitotic cells and its down-stream analysis, is an important parameter in understanding the pathology of cancer, predicting response ...
Hematopoietic stem and progenitor cell (HSPC) transplantation offers a potentially curative therapy for aggressive hematologic malignancies and bone m...
T-cell receptor mimic (TCRm) antibodies are an emerging class of tumor-targeting agents used in advanced immunother-apies such as bispecific T-cell en...